Home / About TBG / Company Introduction

ABOUT

Company Introduction

TBG Diagnostics Limited (TDL) is a global molecular diagnostics company dedicated to the development, manufacture and marketing of molecular diagnostics kits, instruments and services. With its research and development based in the US, Taiwan and China, TDL manufactures its products in its ISO13485 certified facilities in Xiamen, China serving the clinical labs of both hospitals and independent reference labs, blood centers and bone marrow registry labs around the world.

1999

Texas BioGene Inc (TBG) was founded in Texas, USA

2006

Medigen Biotechnology acquired Texas Biogene (TBG)

2007

TBG acquired Shanghai Hao-Yuan, China

2008

Received American Society of Histocompatability and Immunogenetics (ASHI) Accreditation

2009

Submitted 3 in 1 Nucleic Acid testing Kits to SFDA

2010

ID 1st AIDS blood donor in window period

2012

Hao-Yuan acquired by Perkin Elmer for USD $38M

Ongoing global sales of HLA sub-typing kits

2014

Nov.2014 Xiamen subsidiary established

2015

Jan. 2015 Spin off from Medigen

2016

TBG Diagnostics Limited listed on Australian Securities Exchange (ASX) on February 3, 2016 as TDL.